InterOcean Capital Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$303K Sell
1,528
-25
-2% -$4.58K 0.01% 389
2023
Q4
$267K Hold
1,553
0.01% 387
2023
Q3
$230K Sell
1,553
-105
-6% -$19K 0.01% 389
2023
Q2
$362K Sell
1,658
-24
-1% -$5.35K 0.01% 327
2023
Q1
$368K Sell
1,682
-525
-24% -$114K 0.01% 295
2022
Q4
$459K Buy
2,207
+3
+0.1% +$659 0.02% 271
2022
Q3
$481K Sell
2,204
-1,590
-42% -$362K 0.02% 241
2022
Q2
$795K Buy
+3,794
New +$808K 0.03% 188

Other funds holding RMD

InterOcean Capital Group's RMD Position: Q1 2024 in Review

InterOcean Capital Group reduced its ResMed (RMD) stake by 1.6% in Q1 2024, selling an estimated $4.58K and leaving 1,528 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #389.

InterOcean Capital Group first reported a position in RMD in Q2 2022 and has held it in 8 quarters since. The position peaked at $795K in Q2 2022. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • InterOcean Capital Group held 1,528 shares of ResMed worth $303K as of Q1 2024.
  • InterOcean Capital Group sold 25 ResMed shares in Q1 2024, an estimated $4.58K.
  • ResMed made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #389 holding.
  • InterOcean Capital Group first reported a position in ResMed in Q2 2022 and has held it in 8 quarters since.
  • InterOcean Capital Group's ResMed position peaked at $795K in Q2 2022.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.